Marion Houard
Overview
Explore the profile of Marion Houard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zebian G, Kreitmann L, Houard M, Piantoni A, Piga G, Ruffier des Aimes S, et al.
Ann Intensive Care
. 2024 Jun;
14(1):83.
PMID: 38837065
Background: Immunosuppression at intensive care unit (ICU) admission has been associated with a higher incidence of ICU-acquired infections, some of them related to opportunistic pathogens. However, the association of immunosuppression...
2.
Le Berre C, Houard M, Vachee A, Georges H, Wallet F, Patoz P, et al.
Microorganisms
. 2023 Nov;
11(11).
PMID: 38004688
National and international guidelines were recently published regarding the treatment of Enterobacteriaceae resistant to third-generation cephalosporins infections. We aimed to assess the implementation of the French guidelines in critically ill...
3.
Piantoni A, Houard M, Piga G, Zebian G, Ruffier des Aimes S, Holik B, et al.
Antibiotics (Basel)
. 2023 Jul;
12(7).
PMID: 37508201
A bloodstream infection (BSI) is a severe ICU-acquired infection. A growing proportion is caused by multidrug-resistant bacteria (MDRB). COVID-19 was reported to be associated with a high rate of secondary...
4.
Levy C, Dognon N, Normandin S, Duburcq T, Gaudet A, Parmentier-Decrucq E, et al.
Med Intensiva
. 2022 May;
47(1):51-54.
PMID: 35528276
No abstract available.
5.
Goutay J, Perche J, Toussaint A, Drumez E, Howsam M, Bourel C, et al.
Crit Care Res Pract
. 2021 Dec;
2021:3045454.
PMID: 34966560
Objective: Our primary aim was to assess selected metabolic dysfunction parameters, both independently and as a complement to the SOFA score, as predictors of short-term mortality in patients with infection...
6.
Benetazzo L, Delannoy P, Houard M, Wallet F, Lambiotte F, Vachee A, et al.
Antibiotics (Basel)
. 2020 Nov;
9(11).
PMID: 33158238
Objectives: Evaluation of the efficacy of empirical aminoglycoside in critically ill patients with bloodstream infections caused by extended-spectrum β-lactamase producing Enterobacteriaceae (ESBL-E BSI). Methods: Patients treated between 2011 and 2018...
7.
Fischer M, Lemoine S, Tavernier B, Bouchakour C, Colas V, Houard M, et al.
Anesthesiology
. 2020 Mar;
133(1):31-40.
PMID: 32205547
Background: The present trial was designed to assess whether individualized strategies of fluid administration using a noninvasive plethysmographic variability index could reduce the postoperative hospital length of stay and morbidity...
8.
Rouze A, Boddaert P, Martin-Loeches I, Povoa P, Rodriguez A, Ramdane N, et al.
Microorganisms
. 2020 Jan;
8(2).
PMID: 31979375
Objectives: To determine the impact of chronic obstructive pulmonary disease (COPD) on incidence, microbiology, and outcomes of ventilator-associated lower respiratory tract infections (VA-LRTI). Methods: Planned ancillary analysis of TAVeM study,...
9.
Houard M, Rouze A, Ledoux G, Six S, Jaillette E, Poissy J, et al.
PLoS One
. 2018 Aug;
13(8):e0201688.
PMID: 30089150
Background: Ventilator-associated pneumonia (VAP) is the most common ICU-acquired infection. Recently, the incidence of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBLE) has substantially increased in critically ill patients. Identifying patients at risk...